Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
Year: 2016
Type: review
Study designs: Systematic Review, Meta-Analysis
Institutions: IRCCS Humanitas Research Hospital, Universitat Pompeu Fabra, Center for Research in Environmental Epidemiology, Hellenic Center for Disease Control & Prevention, Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université de Lorraine, Humanitas University
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: inflammatory bowel disease, biologic therapy, infection risk, opportunistic infections, serious infections, tuberculosis, cancer risk, TNF-alpha inhibitors, adalimumab, infliximab, vedolizumab, natalizumab, certolizumab, golimumab, drug safety, treatment comparison, indirect treatment comparison
Open Access status: closed
OpenAlex ID: W2372967567
